Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Prednisone for Subacute Thyroiditis
NCT01837433Phase 4Completed
- Sponsor
- Xinqiao Hospital
- Start
- Mar 2013
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone in subacute thyroiditis (SAT) (2 arms), sponsored by Xinqiao Hospital. Primary endpoint: Efficiency of experimental group comparing with control group at 14 days. Started Mar 2013; status: completed.
02
Drugs
prednisone
03
Conditions
subacute thyroiditis (SAT)
Beyond the preview
Go deeper on NCT01837433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01837433.